The intramolecular carboxyarylation approach to podophyllotoxin

Aaron J. Reynolds, Andrew J. Scott, Craig I. Turner, Michael S. Sherburn*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    84 Citations (Scopus)

    Abstract

    Since 1960, only seven plant-derived anticancer drugs have received FDA approval for commercial production. Two are semisynthetic derivatives of podophyllotoxin. This paper describes concise, highly convergent, and conceptually novel approaches to (-)-podophyllotoxin and its enantiomer. These highly convergent syntheses feature a late-stage domino radical reaction to install the lactone ring and the pendant trimethoxyphenyl group.

    Original languageEnglish
    Pages (from-to)12108-12109
    Number of pages2
    JournalJournal of the American Chemical Society
    Volume125
    Issue number40
    DOIs
    Publication statusPublished - 8 Oct 2003

    Fingerprint

    Dive into the research topics of 'The intramolecular carboxyarylation approach to podophyllotoxin'. Together they form a unique fingerprint.

    Cite this